Quick Buzz Feed
NIHCM's latest newsletter highlights the growing use of artificial intelligence in health care, recent shifts in cancer trends, and advancements in treatment. It also features an interview on the emerging role of social media and AI on youth mental health, along with state-level strategies to support well-being.
This section discusses the ongoing rollout of Artificial Intelligence (AI) and other digital technologies within the health care sector, focusing on strategies for their safe and effective implementation. Key points include AI's impact on mental health, where a Bipartisan Policy Center survey found that about 30% of US adults (and nearly 50% of those aged 18-44) use digital mental health tools. Older adults, however, report barriers such as privacy concerns and a preference for personal care. AI is also advancing pancreatic cancer detection, with the Mayo Clinic developing an AI model capable of identifying the cancer on routine abdominal CT scans up to three years before clinical diagnosis. In drug development, OpenAI introduced an early version of its AI model, GPT-Rosalind, to accelerate discovery and support life sciences research, while Novo Nordisk is partnering with OpenAI to integrate AI across its operations, from R&D to supply chains, to keep pace with the obesity drug market. A study in Annals of Internal Medicine, however, indicated that AI-generated clinical notes were of lower quality than human-written notes in simulated primary care cases. The Peterson Health Technology Institute reported on AI's potential to reduce administrative burden and streamline prior authorizations, though it noted that increased provider billing intensity could raise healthcare costs. Resources and initiatives mentioned include the Bipartisan Policy Center's efforts to leverage digital solutions for behavioral health, a JAMA perspective on the need for updated regulatory frameworks for autonomous clinical AI agents amid workforce shortages, BlueCross BlueShield of South Carolina's AI-powered provider coding education platform, Elevance Health's use of AI for fraud, waste, and abuse detection, and GuideWell's application of AI to accelerate prior authorization approvals (with 78% approved in under 90 seconds).
This section features an excerpt from NIHCM’s recent webinar, presenting an interview with Dr. Megan Moreno and Brian Brooks on the intersection of AI and youth mental health. Dr. Moreno, a Professor of Pediatrics and Co-Medical Director for the American Academy of Pediatrics’ Center of Excellence on Social Media and Youth Mental Health, highlights that research in this area is still in its early stages. She observes that youth are increasingly using AI, particularly chatbots, to explore stigmatized topics like mental health, mirroring early internet usage patterns. A critical concern raised is that many of these chatbots were not designed for youth interaction or to provide appropriate responses to mental health queries. Consequently, while young people might use them as a form of practice therapy, the guidance they receive may not adequately prepare them for professional therapy or offer the expected level of support. Brian Brooks, Vice President of Behavioral Health at Blue Cross NC, offers practical, replicable solutions for states to enhance youth mental health support. He suggests that payers can partner with community-based organizations to support provider training, specifically mentioning evidence-based programs like Youth Mental Health First Aid Training. Additionally, he points to Blue Cross NC's collaboration with the state's 988 Lifeline for mobile assessments, noting that the Substance Abuse and Mental Health Services Administration has issued guidelines for mobile youth assessments. Brooks believes more states can adopt this approach and partner with 988 to improve access to behavioral health services for young individuals.
This section delves into recent cancer trends, emphasizing the critical role of prevention, and updates on the latest news regarding treatment advancements for specific cancers. It highlights significant shifts in colorectal cancer (CRC) trends, with the American Cancer Society (ACS) estimating nearly 159,000 new CRCs to be diagnosed in 2026, leading to over 55,000 deaths, with nearly one-third of these fatalities projected in individuals under 65. Despite an overall decline in CRC rates in recent years, incidence has been on the rise among people aged 50 and younger, where it has now become the leading cause of cancer-related death. The importance of preventive screenings is underscored by new research from the Blue Cross Blue Shield Association, which found that cancers detected through preventive screenings are significantly more likely to be identified at an early stage. Specifically, over 80% of breast and colon cancers detected via screenings are diagnosed at stage I. This early detection is directly correlated with substantially lower health care costs; for instance, breast cancer treatment averages $82,900 when caught at stage I, compared to $249,200 at stage IV, and colon cancer treatment costs average $110,900 at stage I versus $255,700 at stage IV. The financial burden of cancer is also addressed, with a recent ACS survey revealing that 47% of cancer patients and survivors carry medical debt related to their cancer. This debt often leads to missed recommended screenings, delayed or skipped treatments, and inadequate access to food. The issue of medical debt is exacerbated for Black and Hispanic patients and survivors, who more frequently reported being denied necessary care due to their outstanding medical debt. Environmental factors also play a role; a study involving over 91,000 people found a statistically significant association between higher exposure to wildfire-related air pollution and an increased risk for several cancers, including lung, colorectal, breast, bladder, and blood cancers, with risk levels escalating with increased exposure. In advancements for pancreatic cancer, which has a challenging five-year survival rate of around 13%, recent developments offer hope. An mRNA vaccine has demonstrated early promise, with a phase 1 clinical trial reporting that nearly 90% of immune responders remained alive up to six years post-treatment. Additionally, the Food and Drug Administration expanded access to an experimental drug, daraxonrasib, which has been shown to roughly double the average survival time for patients receiving conventional treatments. Resources and initiatives related to cancer include May being Skin Cancer Awareness Month, with the Prevent Cancer Foundation offering tips to reduce risk such as sunscreen use, protective clothing, and regular skin checks. The American Cancer Society provides recommended cancer screenings by age. The 2026 Academy of Care Pharmacy meeting saw Horizon Blue Cross Blue Shield of New Jersey address accelerated approval pathways, balancing faster access with clinical uncertainty, while Blue Cross Blue Shield of Michigan highlighted a site-of-care redirection program to manage costs by moving oncology care to lower-cost settings. Premera Blue Cross has enhanced its Personal Health Support program, in partnership with Thyme Care, to offer comprehensive cancer care support, including virtual navigation, assistance with non-clinical barriers, connections to local resources, and support for caregivers.
This section outlines the latest work and announcements from NIHCM, highlighting key achievements and ongoing initiatives. It features the winners of the 32nd Annual NIHCM Health Care Journalism and Policy Research Awards, recognizing high-impact work that delivered novel insights across various topics, including healthcare costs, access, and quality. Also highlighted is the recording of their recent webinar on youth mental health trends and the evolving role of digital technology, providing evidence-based strategies for promoting well-being. A reminder is given for the upcoming deadline (June 8, 2026) for applications to NIHCM’s 2026–2027 Investigator-Initiated Policy Research Grant. The section also showcases projects by journalism grantees, including a podcast series from the Arkansas Center for Health Improvement covering healthy birthing and opportunities to improve maternal and infant health outcomes. Another featured project is a WBUR series exploring how artificial intelligence is shaping patient care, with a recent story diving into OpenEvidence, described as the “ChatGPT for doctors.” Lastly, Tradeoffs' reporting on GLP-1s and the strategies that some employers are implementing to control associated costs is also highlighted through written reporting and a podcast.